Valeant Pharmaceuticals International et al v. Actavis Laboratories FL, Inc. et al
| Valeant Pharmaceuticals International, Cosmo Technologies Limited and Salix Pharmaceuticals Ltd. |
| Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., Actavis Laboratories FL, Inc. and Actavis Pharma, Inc. |
| 1:2018cv01288 |
| August 22, 2018 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent |
| 35 U.S.C. § 271 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 2, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorney John T. Bennett for Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., and Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Filing 38 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,052,286 B2 ;10,064,878 B2 . (Flynn, Michael) |
| Filing 37 First AMENDED COMPLAINT [Jury Demand] against Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.- filed by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International. (Attachments: #1 Exhibits 1-5)(Flynn, Michael) |
| Filing 36 ANSWER to #33 Answer to Complaint,, Counterclaim, by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International.(Flynn, Michael) |
| Filing 35 NOTICE OF SERVICE of Defendants' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) filed by Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc..(Bilson, David) |
| Filing 34 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceuticals USA, Inc. for Actavis Laboratories FL, Inc., Actavis Pharma, Inc.; Corporate Parent Teva Pharmaceuticals Industries Limited for Teva Pharmaceuticals USA, Inc. filed by Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Bilson, David) |
| Filing 33 ANSWER to #1 Complaint, Affirmative Defenses and, COUNTERCLAIM against Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International by Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc..(Bilson, David) |
| Filing 32 Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding proposed scheduling order. (Attachments: #1 Proposed Scheduling Order, #2 Proposed Case Schedule)(Blumenfeld, Jack) |
SO ORDERED, re #31 STIPULATION TO EXTEND TIME for the parties to submit a proposed scheduling order to September 13, 2018 filed by Salix Pharmaceuticals Ltd., Cosmo Technologies Limited, Valeant Pharmaceuticals International. Signed by Judge Leonard P. Stark on 9/13/18. (ntl)
|
| Filing 31 STIPULATION TO EXTEND TIME for the parties to submit a proposed scheduling order to September 13, 2018 - filed by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International. (Flynn, Michael) |
|
SO ORDERED, re #30 STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to September 12, 2018 filed by Teva Pharmaceutical Industries Ltd., Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceuticals USA, Inc. Signed by Judge Leonard P. Stark on 9/10/18. (ntl)
|
| Filing 30 STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to September 12, 2018 - filed by Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Phillips, John) |
| Filing 29 REDACTED VERSION of #19 Letter by Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Exhibit A & B)(Phillips, John) |
| Filing 28 REDACTED VERSION of #23 Letter by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International. (Flynn, Michael) |
| Filing 27 REDACTED VERSION of #12 Letter, by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International. (Flynn, Michael) |
| Filing 26 [SEALED] Transcript of Telephone Conference held on August 30, 2018 before Chief Judge Leonard P. Stark. (bpg) |
|
Filing 25
ORAL ORDER: For the reasons stated during the teleconference yesterday, IT IS HEREBY ORDERED that Plaintiff's Motion for Temporary Restraining Order and Preliminary Injunction (D.I. 5) is DENIED. ORDERED by Judge Leonard P. Stark on 8/31/18. (ntl)
|
| Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 8/30/2018. (Court Reporter B. Gaffigan.) (ntl) |
| Filing 24 REDACTED VERSION of #10 Letter, [NO REDACTIONS] by Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Phillips, John) |
|
SO ORDERED, re #18 MOTION for Pro Hac Vice Appearance of Attorney Paul M. Schoenhard and Thomas P. Steindler filed by Salix Pharmaceuticals Ltd., Cosmo Technologies Limited, Valeant Pharmaceuticals International, #17 MOTION for Pro Hac Vice Appearance of Attorney John T. Bennett filed by Teva Pharmaceutical Industries Ltd., Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceuticals USA, Inc. Signed by Judge Leonard P. Stark on 8/30/18. (ntl)
|
| Filing 23 [SEALED] Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding response to Defendants' letter - re #19 Letter. (Blumenfeld, Jack) |
| Filing 22 REDACTED VERSION of #8 Declaration, -- Declaration of Mark McKenna -- by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International. (Flynn, Michael) |
| Filing 21 REDACTED VERSION of #7 Declaration, -- Declaration of Henry G. Grabowski -- by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International. (Flynn, Michael) |
| Filing 20 REDACTED VERSION of #6 Opening Brief in Support, by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International. (Flynn, Michael) |
| Filing 19 [SEALED] Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding Plaintiffs' request for preliminary relief. (Attachments: #1 Exhibit A, #2 Exhibit B)(Phillips, John) |
| Filing 18 MOTION for Pro Hac Vice Appearance of Attorney Paul M. Schoenhard and Thomas P. Steindler - filed by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International. (Flynn, Michael) |
| Filing 17 MOTION for Pro Hac Vice Appearance of Attorney John T. Bennett - filed by Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Certification of John T. Bennett)(Bilson, David) |
| Pro Hac Vice Attorney Samuel Sherry for Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Pro Hac Vice Attorney Elizabeth J. Holland for Actavis Laboratories FL, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
|
SO ORDERED, re #16 MOTION for Pro Hac Vice Appearance of Attorney Elizabeth J. Holland and Samuel Sherry filed by Teva Pharmaceutical Industries Ltd., Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceuticals USA, Inc. Signed by Judge Leonard P. Stark on 8/28/18. (ntl)
|
| Filing 16 MOTION for Pro Hac Vice Appearance of Attorney Elizabeth J. Holland and Samuel Sherry - filed by Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Certification of Elizabeth J. Holland, #2 Certification of Samuel Sherry)(Bilson, David) |
| Filing 15 NOTICE of Appearance by David A. Bilson on behalf of Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. (Bilson, David) |
| Filing 14 NOTICE of Appearance by John C. Phillips, Jr on behalf of Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. (Phillips, John) |
|
Filing 13
ORAL ORDER: IT IS HEREBY ORDERED that the Court will hold a status teleconference on Thursday, August 30 at 4:00 p.m. to discuss Plaintiffs' motion for a temporary restraining order and preliminary injunction. Plaintiffs' counsel shall initiate the call to (302) 573-4571. ORDERED by Judge Leonard P. Stark on 8/24/18. (ntl)
|
| Filing 12 [SEALED] Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding response to Defendants' August 23, 2018 letter - re #5 MOTION for Temporary Restraining Order and Preliminary Injunction, #10 Letter,. (Attachments: #1 Exhibit A)(Blumenfeld, Jack) |
| Filing 11 STIPULATION Regarding Access to Confidential Information by Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Phillips, John) |
| Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Filing 10 [SEALED] Letter to the Honorable Leonard P. Stark from John C. Phillips, Jr. regarding Plaintiffs' Motion for Temporary Restraining Order and Preliminary Injunction - re #5 MOTION for Temporary Restraining Order and Preliminary Injunction. (Phillips, John) |
| Remark : Exit copy of Motion (DI 5) and Docket Sheet to Duty Judge (GMS). Courtesy copies of sealed documents and accompanying Motion to Seal have been requested to be delivered to the Clerk's Office this morning. (rwc) |
| Remark : Exit copy of DI# 5 and docket sheet to LPS Chambers. (rwc) |
| Filing 9 DECLARATION re #5 MOTION for Temporary Restraining Order and Preliminary Injunction -- Declaration of Stephen R. Byrn Ph.D. -- by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International. (Flynn, Michael) |
| Filing 8 [SEALED] DECLARATION re #5 MOTION for Temporary Restraining Order and Preliminary Injunction -- Declaration of Mark McKenna -- by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International. (Flynn, Michael) |
| Filing 7 [SEALED] DECLARATION re #5 MOTION for Temporary Restraining Order and Preliminary Injunction -- Declaration of Henry G. Grabowski -- by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International. (Flynn, Michael) |
| Filing 6 [SEALED] OPENING BRIEF in Support re #5 MOTION for Temporary Restraining Order and Preliminary Injunction filed by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International.Answering Brief/Response due date per Local Rules is 9/5/2018. (Flynn, Michael) |
| Filing 5 MOTION for Temporary Restraining Order and Preliminary Injunction - filed by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International. (Flynn, Michael) |
| Filing 4 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bausch Health Companies, Inc. for Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International; Corporate Parent Cosmo Pharmaceuticals NV for Cosmo Technologies Limited filed by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International. (crb) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,052,286 B2. (crb) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (crb) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2444833.) - filed by Valeant Pharmaceuticals International, Salix Pharmaceuticals Ltd., Cosmo Technologies Limited. (Attachments: #1 Exhibit 1 - 5, #2 Civil Cover Sheet)(crb) |
| Summons Issued with Magistrate Consent Notice attached as to Actavis Laboratories FL, Inc. on 8/22/2018; Actavis Pharma, Inc. on 8/22/2018; Teva Pharmaceutical Industries Ltd. on 8/22/2018; Teva Pharmaceuticals USA, Inc. on 8/22/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (crb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
